OnKure Therapeutics, Inc. (NASDAQ:OKUR) IPO
IPO
Went public as Reneo Pharmaceuticals, Inc. Priced at US$15.00 a share on Apr 8, 2021.
- Price
- US$15.00 a share
- Shares offered
- 6,250,000 shares of common stock
- Offering size
- US$93.8 million
- Underwriters' option
- Up to 937,500 more shares
- Underwriters
- Jefferies, SVB Leerink, Piper Sandler · In the order on the cover
- Shares delivered
- On or about Apr 13, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 12, 2021 |
| Filed publicly | Mar 19, 2021 |
| Amended once | Apr 5, 2021 |
| Shares registered with an exchange | Apr 6, 2021 |
| Declared effective by the SEC | Apr 8, 2021 |
| Final prospectus, with the price | Apr 9, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 9, 2021 |
| EFFECT · Notice that a registration is effective | Apr 8, 2021 |
| CERT · Exchange's certificate of listing | Apr 8, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 6, 2021 |
| CORRESP · Letter to the SEC | Apr 6, 2021 |
| CORRESP · Letter to the SEC | Apr 6, 2021 |
| S-1/A · Registration statement, amended | Apr 5, 2021 |
| CORRESP · Letter to the SEC | Mar 19, 2021 |
| S-1 · Registration statement | Mar 19, 2021 |
| UPLOAD · Letter from the SEC | Mar 12, 2021 |
| DRS · Draft registration statement | Feb 12, 2021 |
From the cover of the final prospectus (424B4) filed Apr 9, 2021